Note 6 - Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2024

Notes Tables

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

	Warrant shares outstanding			Weighted Average exercise price		Weighted Average remaining life		Intrinsic value
Outstanding at January 1, 2024		314,572			0.50		0.10		59,737
Issued		-			-		-		-
Exercised		(103,500	)		0.50		-		-
Expired or cancelled		(211,072	)		0.50		-		-
Outstanding and exercisable at September 30, 2024		-			-		-		-

Deferred Compensation Arrangement with Individual, Share-based Payments [Table Text Block]

	September 30, 2024			September 30, 2023
Shares-to-be-issued, outstanding January 1, 2024 and 2023, respectively		3,098,917			2,440,673
Granted in current period		438,868			368,387
Issued in current period		(353,102	)		-
Shares-to be issued outstanding September 30, 2024 and 2023, respectively		3,184,683			2,809,060

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

	Number of Options		Weighted Averaged Exercise Price $		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Options Value $
Options outstanding at January 1, 2024		3,036,989		2.29		5.41		-
Granted during 2024		-		-				-
Exercised during 2024		-		-		-		-
Forfeited or expired during 2024		-		-		-		-
Options outstanding September 30, 2024		3,036,989		2.32		4.66		-
Exercisable, September 30, 2024		2,188,433		2.29		4.06		-

	Number of Options			Weighted Averaged Exercise Price $		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Options Value $
Options outstanding at January 1, 2024		91,663			1.76		2.25		2,833
Granted during 2024		24,999			0.84		4.71		-
Exercised during 2024		-			-		-		-
Forfeited or expired during 2024		(16,666	)		0.55		-		-
Options outstanding September 30, 2024		99,996			1.74		2.37		4,083
Exercisable, September 30, 2024		77,772			1.99		1.81		1,916

Restricted Stock [Member]

Notes Tables

Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]

	Number of Shares			Weighted Average Grant-Date Fair Value per Award
Non-vested as January 1, 2024		327,937			0.91
Granted		730,340			0.89
Vested		(510,522	)		0.91
Cancelled		-			-
Non-vested as September 30, 2024		547,755			0.89